fluoxetine has been researched along with 1-naphthylamine in 133 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.75) | 18.7374 |
| 1990's | 132 (99.25) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, K; Bindman, J; Jennings, AL; Phillips, J; Seth, R | 1 |
| Bizzi, A; Caccia, S; Garattini, S; Mennini, T | 1 |
| Kriete, M; Rapoport, JL; Ryland, DH | 1 |
| Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR | 1 |
| Lauder, JM; Sadler, TW; Shuey, DL | 1 |
| Brown, WA; Harrison, W | 2 |
| DeVane, CL | 1 |
| Johnson, AM; Tulloch, IF | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 2 |
| Koe, BK; Lebel, LA; Welch, WM | 1 |
| Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P | 1 |
| Rickels, K; Schweizer, E | 1 |
| Aronson, CE; Brunswick, DJ; Frazer, A; Kovachich, GB | 1 |
| Gupta, AK; Gupta, MA | 1 |
| Rothschild, AJ | 1 |
| Bryant, SG; Fisher, S; Kent, TA | 1 |
| Baumann, P; Rochat, B | 1 |
| Preskorn, SH | 3 |
| Christenson, JL; Cushing, AG; Haider, A; Miller, DR; Station, RD | 1 |
| Auerbach, SB; Rutter, JJ | 1 |
| Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S | 1 |
| Finley, PR | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Carson, W; Jackson, C; Markowitz, J; Mintzer, J | 1 |
| Jaffe, IA | 1 |
| Goldberg, JF; Kocsis, JH; Sacks, MH | 1 |
| Schleis, T | 1 |
| Marman, GW; North, DS | 1 |
| Althof, SE | 1 |
| Helmeste, DM; Reist, C; Tang, SW; Vu, R | 1 |
| Kofoed, L; Stock, AJ | 1 |
| Greist, JH; Jefferson, JW; Katzelnick, DJ; Kobak, KA; Serlin, RC | 1 |
| Kafka, MP | 1 |
| Kaplan, PM | 1 |
| Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF | 1 |
| Preskorn, S | 1 |
| Akpunonu, B; Grubb, BP; Kosinski, D; Samoil, D; Temesy-Armos, P | 1 |
| Deltito, JA | 1 |
| Cline, EJ; Kim, S; Kuhar, MJ; Scheffel, U | 1 |
| Coutaux, AF; Mooney, JJ; Wirth, DF | 1 |
| Jackson, CW; Lydiard, RB; Morton, WA | 1 |
| Iacono, RP; Toyama, SC | 1 |
| Alderman, J; Chung, M; Harris, S; Harrison, W; Messig, M; Preskorn, SH | 1 |
| Calabrese, JR; Rapport, DJ | 1 |
| Aguglia, E; Bolino, F; Casacchia, M; Cassano, GB; Faravelli, C; Ferrari, G; Giordano, P; Pancheri, P; Ravizza, L; Trabucchi, M | 1 |
| Ellison, JM; Stanziani, P | 1 |
| Hollander, E; Josephson, SC; Stein, DJ | 1 |
| Bandettini, F; Bhatara, VS | 1 |
| Lauder, JM; Sadler, TW; Shuey, DL; Tamir, H; Yavarone, MS | 1 |
| Kleven, MS; Woolverton, WL | 1 |
| Kupfer, DJ | 1 |
| Binkley, SN; Ring, BJ; Roskos, L; Wrighton, SA | 1 |
| LaBranche, S | 1 |
| Hsu, JH; Shen, WW | 1 |
| McConnell, JG; Taylor, IC | 1 |
| Burke, MJ; Harvey, AT; Preskorn, SH | 1 |
| Cole, JO; Kando, JC; Tohen, M; Weiss, MK; Zarate, CA | 1 |
| Duman, RS; Nestler, EJ; Nibuya, M | 1 |
| Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT | 1 |
| Bhatara, VS; Freeman, JW; Gupta, S | 1 |
| Berman, R; Charney, DS; Delgado, PL; Heninger, GR; Krystal, JH; Miller, HL; Salomon, RM | 1 |
| Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA | 1 |
| Newhouse, PA | 1 |
| Balon, R | 1 |
| Koran, LM; Maloney, A; Mueller, K | 1 |
| Knowles, SR; Liu, BA; Mittmann, N; Shear, NH | 1 |
| Darmani, NA | 2 |
| Reynolds, CF | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Harvey, AT; Preskorn, SH | 1 |
| Leo, RJ | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR | 1 |
| Kurz, X; Ottervanger, JP; Roisin, T; Stricker, BH; Van Ermen, AM | 1 |
| Bélanger, PM; Hamelin, BA; LeBel, M; Paquet, F; Turgeon, J; Vallée, F | 1 |
| Darmani, NA; Reeves, SL | 1 |
| Baumann, P; Eap, CB | 1 |
| MacKay, AV; Price, JS; Waller, PC; Wood, SM | 1 |
| Bradford, JM; Curry, S; Greenberg, DM; O'Rourke, A | 1 |
| Labbate, LA; Oleshansky, MA | 1 |
| Berti, C; Burnett, F; Cooney, J; Dash, A; Dinan, TG; Lavelle, E; Scott, L; Thakore, J | 1 |
| Apter, JT; Birkett, MA; Blomgren, SL; Tepner, RG; Thase, ME | 1 |
| Daniel, WA; Wójcikowski, J | 2 |
| Rifkin, A | 1 |
| Meier, E; Sánchez, C | 1 |
| Charness, WE; Ferrando, SJ; Goldman, JD | 1 |
| Earley, B; Faherty, CJ; Leonard, BE | 1 |
| Devine, CL; Markowitz, JS | 1 |
| DePalma, RL; Katholi, CR; Modell, JD; Modell, JG | 1 |
| Mellerup, ET; Plenge, P | 1 |
| Agosti, V; Stewart, JW | 1 |
| Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
| Byrne, S; Rothschild, AJ | 1 |
| Darby, AL; Lesser, IM; Miller, BL; Swartz, JR | 1 |
| Constantino, JN; Kincaid, M; Liberman, M | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Findling, RL | 1 |
| Brenner, EM; King, RA; Lynch, KA; Scahill, L; Vitulano, LA | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Jaffe, IA; Rudikoff, D | 1 |
| Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E | 1 |
| Richelson, E | 1 |
| Gregor, KJ; James, SP; Way, K; Young, CH | 1 |
| Bisserbe, JC; Flament, MF | 1 |
| Gorman, JM | 1 |
| Cohen, LS | 1 |
| Cohen, CI; Trappler, B | 1 |
| Edwards, IR; Fletcher, AP; Lindquist, M; Pettersson, M; Sanderson, JH; Schou, JS; Stahl, MM; Taylor, NF | 1 |
| Buesching, DP; Croghan, TW; Crown, WH; Heiligenstein, JH; Hylan, TR; Melfi, CA; Meneades, L | 1 |
| Fawcett, J; Mitchell, S; Zajecka, J | 1 |
| Purdon, SE; Snaterse, M | 1 |
| Grimes, JB; Hines, A; Labbate, LA; Pollack, MH | 1 |
| Evanoff, A; Newton, WP | 1 |
| Mazo, GE; Razorenov, GI; Razorenova, TS; Vovin, RIa | 1 |
| Andrews, W; Barrett, E; Parker, G | 1 |
| Arana, GW; Grimes, JB; Labbate, LA | 1 |
| Ruiz, P; Small, DR; Varner, RV | 1 |
| Goldstein, DJ | 1 |
| Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF | 1 |
| Kim, SC; Seo, KK | 1 |
| Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P | 1 |
| Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS | 1 |
| Roose, SP; Suthers, KM | 1 |
| Navarro, R; Spangler, M; Valler, WE | 1 |
| Bisserbe, JC; Boyer, P; Danion, JM; Hotton, JM; Troy, S | 1 |
32 review(s) available for fluoxetine and 1-naphthylamine
| Article | Year |
|---|---|
Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain; Eating; Fenfluramine; Fluoxetine; Humans; Serotonin; Serotonin Antagonists; Sertraline | 1992 |
Pharmacokinetics of the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Clinical overview of serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine | 1990 |
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism | 1995 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Half-Life; Humans; Metabolic Clearance Rate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
[New antidepressive agents].
Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
Topics: 1-Naphthylamine; Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Use of serotonin selective reuptake inhibitors in geriatric depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Female; Fluoxetine; Fluvoxamine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Depression: making the diagnosis and using SSRIs in the older patient.
Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
Topics: 1-Naphthylamine; Animals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Movement disorders associated with the serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 1996 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline | 1998 |
Antidepressant response in late-life depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
24 trial(s) available for fluoxetine and 1-naphthylamine
| Article | Year |
|---|---|
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer | 1992 |
Are patients who are intolerant to one SSRI intolerant to another?
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1992 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological | 1995 |
Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 1995 |
Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1995 |
Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Fluoxetine; Humans; Male; Middle Aged; Paraphilic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Behavior; Treatment Outcome | 1994 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
Topics: 1-Naphthylamine; Antidepressive Agents; Chromatography, High Pressure Liquid; Desipramine; Dextromethorphan; Drug Interactions; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1993 |
Response to an open trial of a second SSRI in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Brain Chemistry; Depressive Disorder; Desipramine; Diphenhydramine; Dopamine; Fluoxetine; Humans; Mazindol; Methyltyrosines; Norepinephrine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure; Treatment Outcome | 1997 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders | 1997 |
Six month follow-up of early-onset chronic depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Discharge; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome | 1997 |
Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial.
Topics: 1-Naphthylamine; Adolescent; Aggression; Female; Fluoxetine; Humans; Inpatients; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders.
Topics: 1-Naphthylamine; Adult; Anxiety; Ejaculation; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Paroxetine; Penile Erection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 1998 |
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1998 |
Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Double-Blind Method; Ejaculation; Fluoxetine; Humans; Male; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1998 |
Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Antidepressive Agents; Costs and Cost Analysis; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; France; Humans; Male; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
79 other study(ies) available for fluoxetine and 1-naphthylamine
| Article | Year |
|---|---|
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.
Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Nortriptyline; Receptors, Adrenergic; Receptors, Serotonin; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine | 1992 |
Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.
Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Amitriptyline; Animals; Cell Death; Cell Division; Epithelium; Facial Bones; Female; Fluoxetine; Mice; Mice, Inbred ICR; Morphogenesis; Pinocytosis; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Skull; Yolk Sac | 1992 |
If at first you do succeed.
Topics: 1-Naphthylamine; Antidepressive Agents; Benzamides; Depression; Fluoxetine; Half-Life; Humans; Moclobemide; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1991 |
[3H] sertraline binding to rat brain membranes.
Topics: 1-Naphthylamine; Animals; Brain; Fenclonine; Fluoxetine; Imipramine; In Vitro Techniques; Male; Membranes; Naphthalenes; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.
Topics: 1-Naphthylamine; Animals; Autoradiography; Binding, Competitive; Brain; Fluoxetine; Imipramine; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Zimeldine | 1988 |
Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants?
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Female; Fluoxetine; Humans; Middle Aged; Panic Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Urticaria | 1995 |
Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine.
Topics: 1-Naphthylamine; Adult; Adverse Drug Reaction Reporting Systems; Aggression; Ambulatory Care; Confidence Intervals; Data Collection; Drug Monitoring; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Patient Compliance; Probability; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Self Care; Sertraline; Telephone; Weight Gain | 1995 |
Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
Topics: 1-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corpus Striatum; Diencephalon; Fenfluramine; Fluoxetine; Hydroxyindoleacetic Acid; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1993 |
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1993 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
SIADH associated with fluoxetine and sertraline therapy.
Topics: 1-Naphthylamine; Age Factors; Aged; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Inappropriate ADH Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium | 1995 |
Serotonin reuptake inhibitors in Raynaud's phenomenon.
Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1995 |
Attenuation of response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Realities of the fluoxetine-to-sertraline switch.
Topics: 1-Naphthylamine; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tablets | 1995 |
Realities of the fluoxetine-to-sertraline switch.
Topics: 1-Naphthylamine; Dosage Forms; Fluoxetine; Humans; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Equivalency | 1995 |
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.
Topics: 1-Naphthylamine; Blood Platelets; Calcium; Calmodulin; Cells, Cultured; Fluoxetine; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Therapeutic interchange of fluoxetine and sertraline: experience in the clinical setting.
Topics: 1-Naphthylamine; Antidepressive Agents; Drug Costs; Fluoxetine; Humans; Organizational Policy; Pharmacy Service, Hospital; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Equivalency | 1994 |
The use of serotonergic uptake inhibitors in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Ejaculation; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1994 |
The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing.
Topics: 1-Naphthylamine; Aged; Cardiac Pacing, Artificial; Carotid Sinus; Fluoxetine; Follow-Up Studies; Heart Arrest; Humans; Hypotension, Orthostatic; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Syncope; Vasodilation | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.
Topics: 1-Naphthylamine; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Cocaine; Fluoxetine; Hypothalamus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 1994 |
Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.
Topics: 1-Naphthylamine; Animals; Chloroquine; Desipramine; Drug Resistance; Drug Synergism; Fluoxetine; Neurotransmitter Uptake Inhibitors; Plasmodium falciparum; Sertraline | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone | 1994 |
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1994 |
Tolerance to fluoxetine.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
SSRI-associated nocturnal bruxism in four patients.
Topics: 1-Naphthylamine; Adult; Bruxism; Buspirone; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep | 1993 |
Serotonin reuptake blockers for the treatment of obsessional jealousy.
Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealousy; Male; Obsessive-Compulsive Disorder; Pimozide; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Serotonin syndrome and drug interactions.
Topics: 1-Naphthylamine; Drug Interactions; Fluoxetine; Humans; Male; Serotonin; Sertraline | 1993 |
Serotonin and cardiac morphogenesis in the mouse embryo.
Topics: 1-Naphthylamine; Animals; Carrier Proteins; Cell Division; Cell Movement; Female; Fetal Heart; Fluoxetine; Immunohistochemistry; In Vitro Techniques; Mice; Mice, Inbred ICR; Nialamide; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Signal Transduction | 1993 |
Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys.
Topics: 1-Naphthylamine; Animals; Appetitive Behavior; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Fluoxetine; Macaca mulatta; Mazindol; Motivation; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Self Administration; Sertraline | 1993 |
Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.
Topics: 1-Naphthylamine; Catalysis; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1995 |
Severe hyponatraemia associated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Depressive Disorder; Female; Fluoxetine; Humans; Hyponatremia; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Pharmacokinetics of the newer antidepressants.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Desipramine; Fluoxetine; Humans; Isoenzymes; Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Base Sequence; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; Imipramine; In Situ Hybridization; Male; Molecular Sequence Data; Nerve Growth Factors; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkB; Receptors, Nerve Growth Factor; RNA, Messenger; Rolipram; Sertraline; Time Factors; Tranylcypromine | 1996 |
Drug-drug interactions.
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Fluoxetine associated paresthesias and alopecia in a woman who tolerated sertraline.
Topics: 1-Naphthylamine; Adult; Alopecia; Depressive Disorder; Female; Fluoxetine; Humans; Paresthesia; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical | 1996 |
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Head Movements; Male; Mice; Mice, Inbred ICR; Norepinephrine; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1996 |
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Belgium; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.
Topics: 1-Naphthylamine; Adolescent; Adrenergic Agents; Adult; Cytochrome P-450 CYP2D6; Debrisoquin; Fluoxetine; Humans; Male; Methylation; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Effects of antidepressants on the cytochrome P450 system.
Topics: 1-Naphthylamine; Antidepressive Agents; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Medical Records; Paroxetine; Research Design; Sertraline | 1996 |
The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT2A receptor response.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; Animals; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Head Movements; Male; Mice; Mice, Inbred ICR; Norepinephrine; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1996 |
A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Paraphilic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Inability to cry during SRI treatment.
Topics: 1-Naphthylamine; Adult; Crying; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1996 |
Dexamethasone augmentation in treatment-resistant depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Personality Inventory; Pituitary-Adrenal System; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 1997 |
SSRI optimal dose remains at issue.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
Topics: 1-Naphthylamine; Antidepressive Agents; Drug Interactions; Fluoxetine; Humans; Paroxetine; Sertraline | 1997 |
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Female; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires | 1997 |
An affinity-modulating site on neuronal monoamine transport proteins.
Topics: 1-Naphthylamine; Animals; Binding Sites; Biogenic Monoamines; Cerebral Cortex; Citalopram; Corpus Striatum; Female; Fluoxetine; In Vitro Techniques; Kinetics; Neurons; Piperazines; Rats; Receptors, Neurotransmitter; Sertraline; Stereoisomerism | 1997 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Psychiatrists' responses to failure of maintenance therapy with antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attitude of Health Personnel; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Nortriptyline; Recurrence; Sertraline; Treatment Failure | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chemotherapy, Adjuvant; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Methylphenidate; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study.
Topics: 1-Naphthylamine; Adolescent; Behavior Therapy; Child; Combined Modality Therapy; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Erythromelalgia: response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Cyclohexanols; Erythromelalgia; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Paroxetine; Psychotropic Drugs; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Interactions between promazine and antidepressants at the level of cellular distribution.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline | 1997 |
Sertraline for premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
Topics: 1-Naphthylamine; Adverse Drug Reaction Reporting Systems; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; World Health Organization | 1997 |
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Direct Service Costs; Drug Costs; Fee-for-Service Plans; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Models, Econometric; Multivariate Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior | 1997 |
Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia.
Topics: 1-Naphthylamine; Adult; Antipsychotic Agents; Clozapine; Cognition; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 1997 |
Treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1998 |
[Choice of therapeutic tactics in treatment of endogenous depression by means of statusmetric expert system].
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
The SSRI antidepressants: exploring their "other" possible properties.
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 1998 |
Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Cocaine; Fenfluramine; Fluoxetine; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Black and white patients response to antidepressant treatment for major depression.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Black People; Body Weight; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Length of Stay; Male; Middle Aged; Pharmacogenetics; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome; White People | 1998 |
Use of serotonin reuptake inhibitors by women of childbearing potential.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Female; Fluoxetine; Humans; Pregnancy; Pregnancy Outcome; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Antidepressant utilization in managed care: an evaluation of SSRI use in two HMO settings.
Topics: 1-Naphthylamine; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Drug Costs; Drug Utilization Review; Fluoxetine; Humans; Managed Care Programs; Models, Organizational; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; United States | 1995 |